J3060 Injection, taliglucerase alfa 10 u
Also known as: taliglucerase, Elelyso, enzyme replacement therapy
Taliglucerase alfa (Elelyso) 10 units injection is a recombinant enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder affecting glucocerebroside metabolism.
In Plain Language
genetic storage disease treatment; enzyme replacement infusion
Clinical Context
Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy.
RVU Information
CPT J3060 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3060?
CPT J3060 (Injection, taliglucerase alfa 10 u) is a J Codes (Drugs) code. Taliglucerase alfa (Elelyso) 10 units injection is a recombinant enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder affecting glucocerebroside metabolism.
How is J3060 administered?
CPT J3060 is administered by a healthcare provider, typically via injection or infusion. Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy. It is used by Hematology/Oncology, Rare Disease Specialists, Genetic Medicine.
When is CPT J3060 used?
Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and export board-ready case logs — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.